PANCREAZE

Product NDC
50458-347
11-digit product format
504580347
Labeler code
50458
Product ID
50458-347_84df27aa-7ea7-11e8-b709-c19a9d46d017
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
PANCRELIPASE
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
Labeler
Janssen Pharmaceuticals, Inc.
Application
NDA022523
Marketing category
NDA
Marketing start
2016-08-01
Marketing end
2020-05-31
Substance
PANCRELIPASE LIPASE; PANCRELIPASE AMYLASE; PANCRELIPASE PROTEASE
Active strength
2600 [USP'U]/1; [USP'U]/1; [USP'U]/1
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50458-347-60EA - Each50458-347b4296db3-cbc5-4e2a-9507-b8dbc1deee0612016-11-08